Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2)

(2014) Carlos A. Morillo et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: Data from the GISSI-AF trial

(2013) Marcello Disertori et al.   BMC Cardiovascular Disorders

Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)

(2013) Lluís Mont et al.   EUROPEAN HEART JOURNAL

Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial

(2013) Sana M. Al-Khatib et al.   EUROPEAN HEART JOURNAL

Factors Associated With Major Bleeding Events

(2013) Shaun G. Goodman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation

(2012) Jonathan P. Piccini et al.   CIRCULATION

Distribution and Risk Profile of Paroxysmal, Persistent, and Permanent Atrial Fibrillation in Routine Clinical Practice

(2012) Chern-En Chiang et al.   Circulation-Arrhythmia and Electrophysiology

Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: Clinical impact of continuous positive airway pressure therapy

(2012) Yoshihisa Naruse et al.   HEART RHYTHM

Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation

(2012) Greg Flaker et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Subclinical Atrial Fibrillation and the Risk of Stroke

(2012) Jeff S. Healey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Echocardiographic predictors of frequency of paroxysmal atrial fibrillation (AF) and its progression to persistent AF in hypertensive patients with paroxysmal AF: Results from the Japanese Rhythm Management Trial II for Atrial Fibrillation (J-RHYTHM II Study)

(2011) Takeki Suzuki et al.   HEART RHYTHM

Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management)

(2011) Sanjeev Saksena et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban—Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study

(2010)   AMERICAN HEART JOURNAL

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation

(2010) David J. Wilber et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk

(2009) Taya V. Glotzer et al.   Circulation-Arrhythmia and Electrophysiology

Antithrombotic Therapy in Atrial Fibrillation

(2008) Daniel E. Singer et al.   CHEST

Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation

(2008) R. Nieuwlaat et al.   EUROPEAN HEART JOURNAL

Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?

(2008) R. Nieuwlaat et al.   EUROPEAN HEART JOURNAL

Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation

(2008) G. Y. H. Lip et al.   JOURNAL OF INTERNAL MEDICINE